Made to measure: Choosing the optimal regimen in transplant-eligible NDMM
Francesco de Lorenzo (President of ECPC) talks to representatives of European patient advocacy groups at the 2013 European Cancer Congress in Amsterdam about the role of the EurocanPlatform project in future patient care.
Particular focus is drawn onto the lack of information patient organisations currently possess within biomarkers and biobanking, and the general issues surrounding these subjects.
Made to measure: Choosing the optimal regimen in transplant-eligible NDMM
Revolutionising myeloma treatment through immune profiling
Powering equity in cancer care through digital health
Multiple Myeloma: evolving paradigm - Panel Discussion
Advancements in paediatric Acute lymphoblastic leukemia management
Choosing 1st line TKI Wisely in patients with CML
TARGIT trial in intraoperative radiotherapy
Relapsed refractory multiple myeloma
First-line NALIRIFOX shows improvement in OS and PFS in metastatic pancreatic cancer